Portable, tankless inhaled nitric oxide therapy
Raised to date
$16.9M
of $30M offered across 1 Form D filing
Third Pole, Inc. is an innovative biotechnology company dedicated to developing and delivering essential life-sustaining therapies for cardiopulmonary conditions. The company specializes in creating portable, tankless inhaled nitric oxide (iNO) delivery systems to enhance accessibility and patient care.
Third Pole stands out by providing portable, on-demand nitric oxide generation that liberates the therapy from traditional large tanks, making it more accessible for both hospital and home use.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 13, 2025 | Equity | $16.9M/ $30M | Form D/A |
Portable Therapy
eNOfit™ is a miniaturized, wearable device designed for home and travel use that enables patients to receive inhaled nitric oxide therapy conveniently in their daily lives. This device allows for greater patient mobility and independence.
Built for
Hospitals, healthcare facilities, and patients with chronic lung diseases
